Reversing diabetic wound stagnation: macrophage polarization dysregulation as a therapeutic linchpin from pathogenesis to precision interventions

Abstract

The stagnation of diabetic wound healing is a formidable global health challenge that is fundamentally driven by the dysregulation of macrophage plasticity. In the diabetic microenvironment, macrophages remain in a persistent pro-inflammatory (M1) state and fail to transition to the reparative (M2) phenotype essential for tissue regeneration. This review systematically elucidates the molecular pathology of this ‘conversion failure’ from a superficial to an in-depth level and provides a detailed explanation of the mechanisms underlying aberrant macrophage polarization in diabetic wounds, ranging from microenvironmental abnormalities to dysregulated signalling pathways. These perturbations create a vicious cycle of chronic inflammation, impaired angiogenesis, and pathological fibrosis. To address these challenges, we comprehensively outline current therapeutic strategies, including approaches that range from the precision molecular reprogramming of intracellular signalling hubs and gene networks to the engineering of microenvironment-responsive biomaterials capable of neutralizing oxidative stress and responding to pathological cues. Furthermore, we highlight the integration of exogenous bioactivity through stem cell– and exosome-based therapies aimed at replenishing the regenerative niche. Additionally, we critically assess translational bottlenecks, suggesting a paradigm shift from the binary M1/M2 model towards targeting intermediate phenotypes identified by single-cell multiomics. By integrating mechanistic insights with advanced immunomodulatory engineering, this review provides a theoretical framework for developing next-generation precision therapies to reverse the chronic nature of diabetic wounds.

Keywords

Macrophage polarization / Diabetic wound healing / Chronic inflammation / Immunomodulation / Signalling pathway

References

[1] Xu Y, Lu J, Li M, Wang T, Wang K, Cao Q, et al. Diabetes in China part 1: epidemiology and risk factors. Lancet Public Health 2024; 9: e1089-97. https://doi.org/10.1016/S2468-2667(24)00250-0.

[2] GBD 2023 Breast Cancer Collaborators . Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet 2023; 402: 203-234.

[3] Pradhan Nabzdyk L, Kuchibhotla S, Guthrie P, Chun M, Auster ME, Nabzdyk C, et al. Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing. J Vasc Surg 2013; 58: 766-775.e12. https://doi.org/10.1016/j.jvs.2012.11.095.

[4] Goldufsky J, Wood SJ, Jayaraman V, Majdobeh O, Chen L, Qin S, et al. Pseudomonas aeruginosa uses T3SS to inhibit diabetic wound healing. Wound Repair Regen 2015; 23: 557-64. https://doi.org/10.1111/wrr.12310.

[5] Li M, Hou Q, Zhong L, Zhao Y, Fu X. Macrophage related chronic inflammation in non-healing wounds. Front Immunol 2021; 12: 681710. https://doi.org/10.3389/fimmu.2021.681710.

[6] McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care 2023; 46: 209-21. https://doi.org/10.2337/dci22-0043.

[7] Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic foot ulcers: a review. JAMA 2023; 330: 62-75. https://doi.org/10.1001/jama.2023.10578.

[8] Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-24. https://doi.org/10.1016/S0140-6736(05)67698-2.

[9] Aitcheson SM, Frentiu FD, Hurn SE, Edwards K, Murray RZ. Skin wound healing: normal macrophage function and macrophage dysfunction in diabetic wounds. Molecules 2021; 26: 4917. https://doi.org/10.3390/molecules26164917.

[10] Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014; 41: 14-20. https://doi.org/10.1016/j.immuni.2014.06.008.

[11] Murray PJ. Macrophage polarization. Annu Rev Physiol 2017; 79: 541-66. https://doi.org/10.1146/annurev-physiol-022516-034339.

[12] Boniakowski AE, Kimball AS, Jacobs BN, Kunkel SL, Gallagher KA. Macrophage-mediated inflammation in normal and diabetic wound healing. J Immunol (Baltimore, Md.: 1950) 2017; 199: 17-24. https://doi.org/10.4049/jimmunol.1700223.

[13] Hwang J, Zheng M, Wiraja C, Cui M, Yang L, Xu C. Reprogramming of macrophages with macrophage cell membrane-derived nanoghosts. Nanoscale Adv 2020; 2: 5254-62. https://doi.org/10.1039/D0NA00572J.

[14] Bian Z, Gong Y, Huang T, Lee CZW, Bian L, Bai Z, et al. Deciphering human macrophage development at single-cell resolution. Nature 2020; 582: 571-6. https://doi.org/10.1038/s41586-020-2316-7.

[15] Ginhoux F, Guilliams M. Tissue-resident macrophage ontogeny and homeostasis. Immunity 2016; 44: 439-49. https://doi.org/10.1016/j.immuni.2016.02.024.

[16] Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol 2013; 14: 986-95. https://doi.org/10.1038/ni.2705.

[17] Sharifiaghdam M, Shaabani E, Faridi-Majidi R, de Smedt SC, Braeckmans K, Fraire JC. Macrophages as a therapeutic target to promote diabetic wound healing. Mol Ther 2022; 30: 2891-908. https://doi.org/10.1016/j.ymthe.2022.07.016.

[18] Turner AEB, Yu C, Bianco J, Watkins JF, Flynn LE. The performance of decellularized adipose tissue microcarriers as an inductive substrate for human adipose-derived stem cells. Biomaterials 2012; 33: 4490-9. https://doi.org/10.1016/j.biomaterials.2012.03.026.

[19] Randolph GJ, Jakubzick C, Qu C. Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol 2008; 20: 52-60. https://doi.org/10.1016/j.coi.2007.10.010.

[20] Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229: 176-85. https://doi.org/10.1002/path.4133.

[21] Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther 2023; 8: 207. https://doi.org/10.1038/s41392-023-01452-1.

[22] Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327: 656-61.

[23] Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 2018; 233: 6425-40. https://doi.org/10.1002/jcp.26429.

[24] Geng K, Ma X, Jiang Z, Huang W, Gao C, Pu Y, et al. Innate immunity in diabetic wound healing: focus on the mastermind hidden in chronic inflammatory. Front Pharmacol 2021; 12: 653940. https://doi.org/10.3389/fphar.2021.653940.

[25] Peña OA, Martin P. Cellular and molecular mechanisms of skin wound healing. Nat Rev Mol Cell Biol 2024; 25: 599-616. https://doi.org/10.1038/s41580-024-00715-1.

[26] Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11: 889-96. https://doi.org/10.1038/ni.1937.

[27] Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-86. https://doi.org/10.1016/j.it.2004.09.015.

[28] Wu X, He W, Mu X, Liu Y, Deng J, Liu Y, et al. Macrophage polarization in diabetic wound healing. Burns Trauma 2022; 10: tkac051. https://doi.org/10.1093/burnst/tkac051.

[29] Ferrante CJ, Leibovich SJ. Regulation of macrophage polarization and wound healing. Adv Wound Care (New Rochelle) 2012; 1: 10-6. https://doi.org/10.1089/wound.2011.0307.

[30] Viola A, Munari F, Sánchez-Rodríguez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. Front Immunol 2019; 10: 1462. https://doi.org/10.3389/fimmu.2019.01462.

[31] Spiller KL, Anfang RR, Spiller KJ, Ng J, Nakazawa KR, Daulton JW, et al. The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials 2014; 35: 4477-88. https://doi.org/10.1016/j.biomaterials.2014.02.012.

[32] Leal EC, Carvalho E, Tellechea A, Kafanas A, Tecilazich F, Kearney C, et al. Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype. Am J Pathol 2015; 185: 1638-48. https://doi.org/10.1016/j.ajpath.2015.02.011.

[33] Huang SM, Wu CS, Chiu MH, Wu CH, Chang YT, Chen GS, et al. High glucose environment induces M1 macrophage polarization that impairs keratinocyte migration via TNF-α: an important mechanism to delay the diabetic wound healing. J Dermatol Sci 2019; 96: 159-67. https://doi.org/10.1016/j.jdermsci.2019.11.004.

[34] Mirza R, Koh TJ. Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. Cytokine 2011; 56: 256-64. https://doi.org/10.1016/j.cyto.2011.06.016.

[35] Wang P, Wu J, Yang H, Liu H, Yao T, Liu C, et al. Intelligent microneedle patch with prolonged local release of hydrogen and magnesium ions for diabetic wound healing. Bioact Mater 2023; 24: 463-76. https://doi.org/10.1016/j.bioactmat.2023.01.001.

[36] Bannon P, Wood S, Restivo T, Campbell L, Hardman MJ, Mace KA. Diabetes induces stable intrinsic changes to myeloid cells that contribute to chronic inflammation during wound healing in mice. Dis Model Mech 2013; 6: 1434-47. https://doi.org/10.1242/dmm.012237.

[37] Miao M, Niu Y, Xie T, Yuan B, Qing C, Lu S. Diabetes-impaired wound healing and altered macrophage activation: a possible pathophysiologic correlation. Wound Repair Regen 2012; 20: 203-13. https://doi.org/10.1111/j.1524-475X.2012.00772.x.

[38] Okizaki S, Ito Y, Hosono K, Oba K, Ohkubo H, Amano H, et al. Suppressed recruitment of alternatively activated macrophages reduces TGF-β1 and impairs wound healing in streptozotocin-induced diabetic mice. Biomed Pharmacother 2015; 70: 317-25. https://doi.org/10.1016/j.biopha.2014.10.020.

[39] Mould KJ, Jackson ND, Henson PM, Seibold M, Janssen WJ. Single cell RNA sequencing identifies unique inflammatory airspace macrophage subsets. JCI Insight 2019; 4: e126556.

[40] Nagareddy PR, Murphy AJ, Stirzaker RA, Hu Y, Yu S, Miller RG, et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab 2013; 17: 695-708. https://doi.org/10.1016/j.cmet.2013.04.001.

[41] Louiselle AE, Niemiec SM, Zgheib C, Liechty KW. Macrophage polarization and diabetic wound healing. Transl Res 2021; 236: 109-16. https://doi.org/10.1016/j.trsl.2021.05.006.

[42] Morey M, O’Gaora P, Pandit A, Hélar y C. Hyperglycemia acts in synergy with hypoxia to maintain the pro-inflammatory phenotype of macrophages. PLoS One 2019; 14: e0220577. https://doi.org/10.1371/journal.pone.0220577.

[43] Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One 2010; 5: e9539. https://doi.org/10.1371/journal.pone.0009539.

[44] Ariel A, Serhan CN . New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front Immunol 2012; 3. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2012.00004/full.

[45] Pavlou S, Lindsay J, Ingram R, Xu H, Chen M. Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity. BMC Immunol 2018; 19: 24. https://doi.org/10.1186/s12865-018-0261-0.

[46] Chen H, Shi R, Luo B, Yang X, Qiu L, Xiong J, et al. Macrophage peroxisome proliferator-activated receptor γ deficiency delays skin wound healing through impairing apoptotic cell clearance in mice. Cell Death Dis 2015; 6: e1597. https://doi.org/10.1038/cddis.2014.544.

[47] Wang Q, Zhu G, Cao X, Dong J, Song F, Niu Y. Blocking AGE-RAGE signaling improved functional disorders of macrophages in diabetic wound. J Diabetes Res 2017; 2017: 1-10. https://doi.org/10.1155/2017/1428537.

[48] Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 2005; 67: 3-21. https://doi.org/10.1016/j.diabres.2004.09.004.

[49] He S, Hu Q, Xu X, Niu Y, Chen Y, Lu Y, et al. Advanced glycation end products enhance M1 macrophage polarization by activating the MAPK pathway. Biochem Biophys Res Commun 2020; 525: 334-40. https://doi.org/10.1016/j.bbrc.2020.02.053.

[50] Guo Y, Lin C, Xu P, Wu S, Fu X, Xia W, et al. AGEs induced autophagy impairs cutaneous wound healing via stimulating macrophage polarization to M1 in diabetes. Sci Rep 2016; 6: 36416. https://doi.org/10.1038/srep36416.

[51] Accipe L, Abadie A, Neviere R, Bercion S. Antioxidant activities of natural compounds from Caribbean plants to enhance diabetic wound healing. Antioxidants (Basel) 2023; 12: 1079. https://doi.org/10.3390/antiox12051079.

[52] Liechty C, Hu J, Zhang L, Liechty KW, Xu J. Role of microRNA-21 and its underlying mechanisms in inflammatory responses in diabetic wounds. Int J Mol Sci 2020; 21: 3328. https://doi.org/10.3390/ijms21093328.

[53] Rendra E, Riabov V, Mossel DM, Sevastyanova T, Harmsen MC, Kzhyshkowska J. Reactive oxygen species (ROS) in macrophage activation and function in diabetes. Immunobiology 2019; 224: 242-53. https://doi.org/10.1016/j.imbio.2018.11.010.

[54] Chen L, DiPietro LA. Toll-like receptor function in acute wounds. Adv Wound Care (New Rochelle) 2017; 6: 344-55. https://doi.org/10.1089/wound.2017.0734.

[55] Miller LS, Modlin RL. Toll-like receptors in the skin. Semin Immunopathol 2007; 29: 15-26. https://doi.org/10.1007/s00281-007-0061-8.

[56] Wang S, Liu Y, Wang X, Chen L, Huang W, Xiong T, et al. Modulating macrophage phenotype for accelerated wound healing with chlorogenic acid-loaded nanocomposite hydrogel. J Control Release 2024; 369: 420-43. https://doi.org/10.1016/j.jconrel.2024.03.054.

[57] Teh HX, Phang SJ, Looi ML, Kuppusamy UR, Arumugam B. Molecular pathways of NF-KB and NLRP3 inflammasome as potential targets in the treatment of inflammation in diabetic wounds: a review. Life Sci 2023; 334: 122228. https://doi.org/10.1016/j.lfs.2023.122228.

[58] Wang S, Lu M, Wang W, Yu S, Yu R, Cai C, et al. Macrophage polarization modulated by NF-κB in polylactide membranes-treated peritendinous adhesion. Small 2022; 18: e2104112. https://doi.org/10.1002/smll.202104112.

[59] Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab 2011; 13: 11-22. https://doi.org/10.1016/j.cmet.2010.12.008.

[60] El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008; 205: 2409-17. https://doi.org/10.1084/jem.20081188.

[61] Sanusi KO, Asiwe JN, Sulaimon FA, Bashar F, Yusuf SK, Abdulkadir HO. Diabetic neuropathy and wound healing: an update on epigenetic crosstalk. World J Diabetes 2025; 16: 110428. https://doi.org/10.4239/wjd.v16.i11.110428.

[62] Zhao J, Yang S, Shu B, Chen L, Yang R, Xu Y, et al. Transient high glucose causes persistent vascular dysfunction and delayed wound healing by the DNMT1-mediated ang-1/NF-κB pathway. J Invest Dermatol 2021; 141: 1573-84. https://doi.org/10.1016/j.jid.2020.10.023.

[63] Yadu N, Singh M, Singh D, Keshavkant S. Mechanistic insights of diabetic wound: healing process, associated pathways and microRNA-based delivery systems. Int J Pharm 2025; 670: 125117. https://doi.org/10.1016/j.ijpharm.2024.125117.

[64] Hong WX, Hu MS, Esquivel M, Liang GY, Rennert RC, McArdle A, et al. The role of hypoxia-inducible factor in wound healing. Adv Wound Care (New Rochelle) 2014; 3: 390-9. https://doi.org/10.1089/wound.2013.0520.

[65] Díaz-Bulnes P, Saiz ML, López-Larrea C, Rodríguez RM. Crosstalk between hypoxia and ER stress response: a key regulator of macrophage polarization. Front Immunol 2019; 10: 2951. https://doi.org/10.3389/fimmu.2019.02951.

[66] Patel SA, Simon MC. Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ 2008; 15: 628-34. https://doi.org/10.1038/cdd.2008.17.

[67] Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012; 122: 787-95. https://doi.org/10.1172/JCI59643.

[68] Imtiyaz HZ, Simon MC. Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 2010; 345: 105-20. https://doi.org/10.1007/82_2010_74.

[69] Han S, Xu W, Wang Z, Qi X, Wang Y, Ni Y, et al. Crosstalk between the HIF-1 and toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment. Oncotarget 2016; 7: 37773-89. https://doi.org/10.18632/oncotarget.9329.

[70] D’Ignazio L, Batie M, Rocha S. Hypoxia and inflammation in cancer, focus on HIF and NF-κB. Biomedicines 2017; 5: 21. https://doi.org/10.3390/biomedicines5020021.

[71] D’Ignazio L, Bandarra D, Rocha S. NF-κB and HIF crosstalk in immune responses. FEBS J 2016; 283: 413-24. https://doi.org/10.1111/febs.13578.

[72] Liang J, Ran Y, Hu C, Zhou J, Ye L, Su W, et al. Inhibition of HIF-1α ameliorates pulmonary fibrosis by suppressing M2 macrophage polarization through PRMT1/STAT6 signals. Int Immunopharmacol 2025; 146: 113931. https://doi.org/10.1016/j.intimp.2024.113931.

[73] Shaabani E, Sharifiaghdam M, Lammens J, de Keersmaecker H, Vervaet C, de Beer T, et al. Increasing angiogenesis factors in hypoxic diabetic wound conditions by siRNA delivery: additive effect of LbL-gold nanocarriers and desloratadine-induced lysosomal escape. Int J Mol Sci 2021; 22: 9216. https://doi.org/10.3390/ijms22179216.

[74] Huang X, Zheng L, Zhou Y, Hu S, Ning W, Li S, et al. Controllable adaptive molybdate-oligosaccharide nanoparticles regulate M2 macrophage mitochondrial function and promote angiogenesis via PI3K/HIF-1α/VEGF pathway to accelerate diabetic wound healing. Adv Healthc Mater 2024; 13: e2302256. https://doi.org/10.1002/adhm.202302256.

[75] Wang F, Zhang S, Vuckovic I, Jeon R, Lerman A, Folmes CD, et al. Glycolytic stimulation is not a requirement for M2 macrophage differentiation. Cell Metab 2018; 28: 463-475.e4. https://doi.org/10.1016/j.cmet.2018.08.012.

[76] Qian L, Chen XQ, Kong D, Wang G, Cao Y, Xiao Y, et al. MK8617 inhibits M1 macrophage polarization and inflammation via the HIF-1α/GYS1/UDPG/P2Y14 pathway. PeerJ 2023; 11: e15591. https://doi.org/10.7717/peerj.15591.

[77] Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol 2018; 9: 586. https://doi.org/10.3389/fimmu.2018.00586.

[78] Jiang N, Xu C, Xu Y, Zhuo Y, Chen P, Deng S, et al. Comprehensive transcriptomic analysis of immune-related genes in diabetic foot ulcers: new insights into mechanisms and therapeutic targets. Int Immunopharmacol 2024; 139: 112638. https://doi.org/10.1016/j.intimp.2024.112638.

[79] Liu Y, Zhang M, Zeng L, Lai Y, Wu S, Su X. Wogonin upregulates SOCS3 to alleviate the injury in diabetic nephropathy by inhibiting TLR4-mediated JAK/STAT/AIM2 signaling pathway. Mol Med 2024; 30: 78.

[80] Odegaard JI, Chawla A. Alternative macrophage activation and metabolism. Annu Rev Pathol 2011; 6: 275-97. https://doi.org/10.1146/annurev-pathol-011110-130138.

[81] Liu K, Zhao E, Ilyas G, Lalazar G, Lin Y, Haseeb M, et al. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization. Autophagy 2015; 11: 271-84. https://doi.org/10.1080/15548627.2015.1009787.

[82] Kamal R, Awasthi A, Pundir M, Thakur S. Healing the diabetic wound: unlocking the secrets of genes and pathways. Eur J Pharmacol 2024; 975: 176645. https://doi.org/10.1016/j.ejphar.2024.176645.

[83] Sawaya AP, Stone RC, Brooks SR, Pastar I, Jozic I, Hasneen K et al. Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing. Nat Commun 2020; 11: 4678. https://doi.org/10.1038/s41467-020-18276-0.

[84] Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007; 447: 1116-20. https://doi.org/10.1038/nature05894.

[85] Yu T, Gao M, Yang P, Liu D, Wang D, Song F, et al. Insulin promotes macrophage phenotype transition through PI3K/akt and PPAR-γ signaling during diabetic wound healing. J Cell Physiol 2019; 234: 4217-31. https://doi.org/10.1002/jcp.27185.

[86] Necela BM, Su W, Thompson EA. Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages. Immunology 2008; 125: 344-58. https://doi.org/10.1111/j.1365-2567.2008.02849.x.

[87] Levy DM, Terenghi G, Gu XH, Abraham RR, Springall DR, Polak JM. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia 1992; 35: 889-97. https://doi.org/10.1007/BF00399938.

[88] Pittenger GL, Ray M, Burcus NI, McNulty P, Basta B, Vinik AI. Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 2004; 27: 1974-9. https://doi.org/10.2337/diacare.27.8.1974.

[89] Li X, Yi M, Song Z, Ni T, Tu L, Yu M, et al. A calcitonin gene-related peptide co-crosslinked hydrogel promotes diabetic wound healing by regulating M2 macrophage polarization and angiogenesis. Acta Biomater 2025; 196: 109-22. https://doi.org/10.1016/j.actbio.2025.02.046.

[90] Pradhan L, Nabzdyk C, Andersen ND, LoGerfo FW, Veves A. Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med 2009; 11: e2. https://doi.org/10.1017/S1462399409000945.

[91] Volmer-Thole M, Lobmann R . Neuropathy and diabetic foot syndrome. Int J Mol Sci 2016; 17: 917. https://doi.org/10.3390/ijms17060917.

[92] Lu YZ, Nayer B, Singh SK, Alshoubaki YK, Yuan E, Park AJ, et al. CGRP sensory neurons promote tissue healing via neutrophils and macrophages. Nature 2024; 628: 604-11. https://doi.org/10.1038/s41586-024-07237-y.

[93] Hamiti Y, Liu K, Wang S, Yang X, Kadier X, Yusufu A. CGRP-dependent molecular signaling drives bone marrow stem cell osteogenesis in distraction osteogenesis. Front Bioeng Biotechnol 2025; 13: 1641476. https://doi.org/10.3389/fbioe.2025.1641476.

[94] Al-Karagholi MA, Kalatharan V, Fagerberg PS, Amin FM. The vascular role of CGRP: a systematic review of human studies. Front Neurol 2023; 14: 1204734. https://doi.org/10.3389/fneur.2023.1204734.

[95] Luan B, Yoon YS,Le Lay J, Kaestner KH,Hedrick S, Montminy M. CREB pathway links PGE2 signaling with macrophage polarization. Proc Natl Acad Sci U S A 2015; 112: 15642-7. https://doi.org/10.1073/pnas.1519644112.

[96] Wang J, Han Y, Huang F, Tang L, Mu J, Liang Y. Diabetic macrophage small extracellular vesicles-associated miR-503/IGF1R axis regulates endothelial cell function and affects wound healing. Front Immunol 2023; 14: 1104890. https://doi.org/10.3389/fimmu.2023.1104890.

[97] Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 2016; 44: 450-62. https://doi.org/10.1016/j.immuni.2016.02.015.

[98] Gurevich DB, Severn CE, Twomey C, Greenhough A, Cash J, Toye AM, et al. Live imaging of wound angiogenesis reveals macrophage orchestrated vessel sprouting and regression. EMBO J 2018; 37: e97786. https://doi.org/10.15252/embj.201797786.

[99] Jetten N, Verbruggen S, Gijbels MJ, Post MJ, de Winther MPJ, Donners MMPC. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 2014; 17: 109-18. https://doi.org/10.1007/s10456-013-9381-6.

[100] Zajac E, Schweighofer B, Kupriyanova TA, Juncker-Jensen A, Minder P, Quigley JP et al. Angiogenic capacity of M1-and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood 2013; 122: 4054-67. https://doi.org/10.1182/blood-2013-05-501494.

[101] Chambers SEJ, O’Neill CL, O’Doherty TM, Medina RJ, Stitt AW. The role of immune-related myeloid cells in angiogenesis. Immunobiology 2013; 218: 1370-5. https://doi.org/10.1016/j.imbio.2013.06.010.

[102] Kodelja V, Müller C, Tenorio S, Schebesch C, Orfanos CE, Goerdt S. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 1997; 197: 478-93. https://doi.org/10.1016/S0171-2985(97)80080-0.

[103] Liu C, Lv M, Xu Q, Xie J, You Y, Guo K, et al. Chronological adaptive polyoxometalate-based hydrogel for diabetic chronic wounds through synchronous bacterial ferroptosis death and immunomodulation. Nano Today 2024; 58: 102415. https://doi.org/10.1016/j.nantod.2024.102415.

[104] Giraudo E, Inoue M, Hanahan D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 2004; 114: 623-33. https://doi.org/10.1172/JCI200422087.

[105] Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-44. https://doi.org/10.1038/35036374.

[106] Ogata Y, Itoh Y, Nagase H. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J Biol Chem 1995; 270: 18506-11. https://doi.org/10.1074/jbc.270.31.18506.

[107] Cui L, Zhao Y, Zhong Y, Zhang L, Zhang X, Guo Z, et al. Combining decellularized adipose tissue with decellularized adventitia extravascular matrix or small intestinal submucosa matrix for the construction of vascularized tissue-engineered adipose. Acta Biomater 2023; 170: 567-79. https://doi.org/10.1016/j.actbio.2023.08.060.

[108] Zhao F, Lei B, Li X, Mo Y, Wang R, Chen D, et al. Promoting in vivo early angiogenesis with sub-micrometer strontium-contained bioactive microspheres through modulating macrophage phenotypes. Biomaterials 2018; 178: 36-47. https://doi.org/10.1016/j.biomaterials.2018.06.004.

[109] Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res 2010; 89: 219-29. https://doi.org/10.1177/0022034509359125.

[110] Knipper JA, Willenborg S, Brinckmann J, Bloch W, Maaß T, Wagener R, et al. Interleukin-4 receptor α signaling in myeloid cells controls collagen fibril assembly in skin repair. Immunity 2015; 43: 803-16. https://doi.org/10.1016/j.immuni.2015.09.005.

[111] Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010; 30: 245-57. https://doi.org/10.1055/s-0030-1255354.

[112] Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11: 723-37. https://doi.org/10.1038/nri3073.

[113] Mirza RE, Fang MM, Weinheimer-Haus EM, Ennis WJ, Koh TJ. Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes 2014; 63: 1103-14. https://doi.org/10.2337/db13-0927.

[114] Guo Q, Li W, Xie R, Wang Y, Xie Y, Cheng K, et al. Visualization of the relationship between macrophage and wound healing from the perspective of bibliometric analysis. Int Wound J 2024; 21: e14597. https://doi.org/10.1111/iwj.14597.

[115] Allen JE. IL-4 and IL-13: regulators and effectors of wound repair. Annu Rev Immunol 2023; 41: 229-54. https://doi.org/10.1146/annurev-immunol-101921-041206.

[116] Hachim D, LoPresti ST, Yates CC, Brown BN. Shifts in macrophage phenotype at the biomaterial interface via IL-4 eluting coatings are associated with improved implant integration. Biomaterials 2017; 112: 95-107. https://doi.org/10.1016/j.biomaterials.2016.10.019.

[117] Kuan CH, Chang L, Ho CY, Tsai CH, Liu YC, Huang WY, et al. Immunomodulatory hydrogel orchestrates pro-regenerative response of macrophages and angiogenesis for chronic wound healing. Biomaterials 2025; 314: 122848. https://doi.org/10.1016/j.biomaterials.2024.122848.

[118] Gong L, Li J, Zhang J, Pan Z, Liu Y, Zhou F, et al. An interleukin-4-loaded bi-layer 3D printed scaffold promotes osteochondral regeneration. Acta Biomater 2020; 117: 246-60. https://doi.org/10.1016/j.actbio.2020.09.039.

[119] Yu DM, Zhao J, Lee EE, Kim D, Mahapatra R, Rose EK, et al. GLUT3 promotes macrophage signaling and function via RAS-mediated endocytosis in atopic dermatitis and wound healing. J Clin Invest 2023; 133: e170706. https://doi.org/10.1172/JCI170706.

[120] Zhu X, Zhang C, Jiang W, Zeng Z, Zhang K, du M, et al. Trem2 acts as a non-classical receptor of interleukin-4 to promote diabetic wound healing. Clin Transl Med 2024; 14: e70026. https://doi.org/10.1002/ctm2.70026.

[121] Wei T, Pan T, Peng X, Zhang M, Guo R, Guo Y, et al. Janus liposozyme for the modulation of redox and immune homeostasis in infected diabetic wounds. Nat Nanotechnol 2024; 19: 1178-89. https://doi.org/10.1038/s41565-024-01660-y.

[122] Lee J, Rodero MP, Patel J, Moi D, Mazzieri R, Khosrotehrani K. Interleukin-23 regulates interleukin-17 expression in wounds, and its inhibition accelerates diabetic wound healing through the alteration of macrophage polarization. FASEB J 2018; 32: 2086-94. https://doi.org/10.1096/fj.201700773R.

[123] He X, Gao S, Li H, Liu H, Zhao S, Wang H, et al. Hybrid hydrogel loaded with natural plant extract accelerates diabetic wound healing via ROS scavenging and immunoregulation. Chem Eng J 2024; 499: 156388. https://doi.org/10.1016/j.cej.2024.156388.

[124] Tu C, Lu H, Zhou T, Zhang W, Deng L, Cao W, et al. Promoting the healing of infected diabetic wound by an anti-bacterial and nano-enzyme-containing hydrogel with inflammation-suppressing, ROS-scavenging, oxygen and nitric oxide-generating properties. Biomaterials 2022; 286: 121597. https://doi.org/10.1016/j.biomaterials.2022.121597.

[125] Chen J, Ma H, Meng Y, Liu Q, Wang Y, Lin Y, et al. Analysis of the mechanism underlying diabetic wound healing acceleration by calycosin-7-glycoside using network pharmacology and molecular docking. Phytomedicine 2023; 114: 154773. https://doi.org/10.1016/j.phymed.2023.154773.

[126] Feng Y, Xiao K, Chen J, Lin J, He Y, He X, et al. Immune-microenvironment modulatory polyurethane-hyaluronic acid hybrid hydrogel scaffolds for diabetic wound treatment. Carbohydr Polym 2023; 320: 121238. https://doi.org/10.1016/j.carbpol.2023.121238.

[127] Theocharidis G, Thomas BE, Sarkar D, Mumme HL, Pilcher WJR, Dwivedi B, et al. Single cell transcriptomic landscape of diabetic foot ulcers. Nat Commun 2022; 13: 181. https://doi.org/10.1038/s41467-021-27801-8.

[128] Peng X, He F, Mao Y, Lin Y, Fang J, Chen Y, et al. miR-146a promotes M2 macrophage polarization and accelerates diabetic wound healing by inhibiting the TLR4/NF-κB axis. J Mol Endocrinol 2022; 69: 315-27. https://doi.org/10.1530/JME-21-0019.

[129] Li C, Xiong Y, Fu Z, Ji Y, Yan J, Kong Y, et al. The direct binding of bioactive peptide andersonin-W1 to TLR4 expedites the healing of diabetic skin wounds. Cell Mol Biol Lett 2024; 29: 24. https://doi.org/10.1186/s11658-024-00542-4.

[130] Liu X, Guo C, Yang W, Wang W, Diao N, Cao M, et al. Composite microneedles loaded with Astragalus membranaceus polysaccharide nanoparticles promote wound healing by curbing the ROS/NF-κB pathway to regulate macrophage polarization. Carbohydr Polym 2024; 345: 122574. https://doi.org/10.1016/j.carbpol.2024.122574.

[131] Wang ZL, Li LY, Liu HJ, Fan YL, Shen YX, Song F, et al. Platelet-rich plasma/chitosan/chondroitin sulfate immunomodulatory hydrogel co-networks for diabetic wound repair: functions and molecular mechanisms. Chem Eng J 2024; 491: 152138. https://doi.org/10.1016/j.cej.2024.152138.

[132] Li C, Fu Z, Jin T, Liu Y, Liu N, Yin S, et al. A frog peptide provides new strategies for the intervention against skin wound healing. Cell Mol Biol Lett 2023; 28: 61. https://doi.org/10.1186/s11658-023-00468-3.

[133] He S, Li Z, Wang L, Yao N, Wen H, Yuan H, et al. A nanoenzyme-modified hydrogel targets macrophage reprogramming-angiogenesis crosstalk to boost diabetic wound repair. Bioact Mater 2024; 35: 17-30. https://doi.org/10.1016/j.bioactmat.2024.01.005.

[134] Duan T, Du Y, Xing C, Wang HYY, Wang RF, et al. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol 2022; 13: 812774. https://doi.org/10.3389/fimmu.2022.812774.

[135] Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16: 3-9. https://doi.org/10.1016/j.smim.2003.10.003.

[136] Geng K, Ma X, Jiang Z, Huang W, Gu J, Wang P, et al. High glucose-induced STING activation inhibits diabetic wound healing through promoting M1 polarization of macrophages. Cell Death Discov 2023; 9: 136. https://doi.org/10.1038/s41420-023-01425-x.

[137] Salauddin M, Bhattacharyya D, Samanta I, Saha S, Xue M, Hossain MG, et al. Role of TLRs as signaling cascades to combat infectious diseases: a review. Cell Mol Life Sci 2025; 82: 122. https://doi.org/10.1007/s00018-025-05631-x.

[138] Zhang G, Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001; 107: 13-9. https://doi.org/10.1172/JCI11837.

[139] Xia W, Liu Y, Jiang X, Li M, zheng S, Zhang Z, et al. Lean adipose tissue macrophage derived exosome confers immunoregulation to improve wound healing in diabetes. J Nanobiotechnology 2023; 21: 128. https://doi.org/10.1186/s12951-023-01869-4.

[140] Shi Y, Wang S, Wang K, Yang R, Liu D, Liao H, et al. Relieving macrophage dysfunction by inhibiting SREBP2 activity: a hypoxic mesenchymal stem cells-derived exosomes loaded multifunctional hydrogel for accelerated diabetic wound healing. Small 2024; 20: e2309276. https://doi.org/10.1002/smll.202309276.

[141] Ge L, Wang K, Lin H, Tao E, Xia W, Wang F, et al. Engineered exosomes derived from miR-132-overexpresssing adipose stem cells promoted diabetic wound healing and skin reconstruction. Front Bioeng Biotechnol 2023; 11: 1129538. https://doi.org/10.3389/fbioe.2023.1129538.

[142] Li K, Wu L, Jiang J. Apigenin accelerates wound healing in diabetic mice by promoting macrophage M2-type polarization via increasing miR-21 expression. Mol Cell Biochem 2024; 479: 3119-27. https://doi.org/10.1007/s11010-023-04885-y.

[143] Hao Y, Yang L, Liu Y, Ye Y, Wang J, Yu C, et al. Mmu-miR-145a-5p accelerates diabetic wound healing by promoting macrophage polarization toward the M2 phenotype. Front Med 2021; 8: 775523. https://doi.org/10.3389/fmed.2021.775523.

[144] Wang J, Zhang C, Zhang W, Liu W, Guo Y, Dang P, et al. Ultrathin WO_x nanoribbons with moderate ROS clearance and antibacterial abilities efficiently induce M2 macrophage polarization for diabetic bone defect repair. Adv Funct Mater 2024; 34: 2306319. https://doi.org/10.1002/adfm.202306319.

[145] Kong J, Ma S, Chu R, Liu J, Yu H, Mao M, et al. Photothermal and photocatalytic glycol chitosan and polydopamine-grafted oxygen vacancy bismuth oxyiodide (BiO_1-xI) nanoparticles for the diagnosis and targeted therapy of diabetic wounds. Adv Mater 2024; 36: e2307695. https://doi.org/10.1002/adma.202307695.

[146] Dunnill C, Patton T, Brennan J, Barrett J, Dryden M, Cooke J, et al. Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process. Int Wound J 2017; 14: 89-96. https://doi.org/10.1111/iwj.12557.

[147] Kim YW, Byzova TV. Oxidative stress in angiogenesis and vascular disease. Blood 2014; 123: 625-31. https://doi.org/10.1182/blood-2013-09-512749.

[148] Sies H. Oxidative eustress: on constant alert for redox homeostasis. Redox Biol 2021; 41: 101867. https://doi.org/10.1016/j.redox.2021.101867.

[149] Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol 2020; 21: 363-83. https://doi.org/10.1038/s41580-020-0230-3.

[150] Yao Y, Zang Y, Qu J, Tang M, Zhang T. The toxicity of metallic nanoparticles on liver: the subcellular damages, mechanisms, and outcomes. Int J Nanomedicine 2019; 14: 8787-804. https://doi.org/10.2147/IJN.S212907.

[151] Yu M, Wang S, Lin D. Mechanism and application of biomaterials targeting reactive oxygen species and macrophages in inflammation. Int J Mol Sci 2024; 26: 245. https://doi.org/10.3390/ijms26010245.

[152] Verkhovskii RA, Ivanov AN, Lengert EV, Tulyakova K, Shilyagina N, Ermakov A. Current principles, challenges, and new metrics in pH-responsive drug delivery systems for systemic cancer therapy. Pharmaceutics 2023; 15: 1566. https://doi.org/10.3390/pharmaceutics15051566.

[153] Lee SH, Gupta MK, Bang JB, Bae H, Sung HJ. Current progress in reactive oxygen species (ROS)-responsive materials for biomedical applications. Adv Healthc Mater 2013; 2: 908-15. https://doi.org/10.1002/adhm.201200423.

[154] Zhou X, Brown BA, Siegel AP, el Masry MS, Zeng X, Song W, et al. Exosome-mediated crosstalk between keratinocytes and macrophages in cutaneous wound healing. ACS Nano 2020; 14: 12732-48. https://doi.org/10.1021/acsnano.0c03064.

[155] Yao WD, Zhou JN, Tang C, Zhang JL, Chen ZY, Li Y, et al. Hydrogel microneedle patches loaded with stem cell mitochondria-enriched microvesicles boost the chronic wound healing. ACS Nano 2024; 18: 26733-50. https://doi.org/10.1021/acsnano.4c06921.

[156] Ma W, Zhang X, Liu Y, Fan L, Gan J, Liu W, et al. Polydopamine decorated microneedles with Fe-MSC-derived nanovesicles encapsulation for wound healing. Adv Sci 2022; 9: e2103317. https://doi.org/10.1002/advs.202103317.

[157] De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100-6. https://doi.org/10.1038/nbt1274.

[158] Motegi SI, Ishikawa O. Mesenchymal stem cells: the roles and functions in cutaneous wound healing and tumor growth. J Dermatol Sci 2017; 86: 83-9. https://doi.org/10.1016/j.jdermsci.2016.11.005.

[159] Zang H, Jiang H, Huang J, el Akkawi MM, Yan L, Liang K, et al. Bilayer micropatterned hydrogel scaffolds loaded with ADSCs improved integration with regenerated tissue and diabetic wound healing. Chem Eng J 2024; 489: 151342. https://doi.org/10.1016/j.cej.2024.151342.

[160] Ouyang L, Qiu D, Fu X, Wu A, Yang P, Yang Z et al. Overexpressing HPGDS in adipose-derived mesenchymal stem cells reduces inflammatory state and improves wound healing in type 2 diabetic mice. Stem Cell Res Ther 2022; 13: 395. https://doi.org/10.1186/s13287-022-03082-w.

[161] Zheng Y, Zheng S, Fan X, Li L, Xiao Y, Luo P, et al. Amniotic epithelial cells accelerate diabetic wound healing by modulating inflammation and promoting neovascularization. Stem Cells Int 2018; 2018: 1-10. https://doi.org/10.1155/2018/1082076.

[162] Benchaprathanphorn K, Muangman P, Chinaroonchai K, Namviriyachote N, Ampawong S, Angkhasirisap W, et al. Translational application of human keratinocyte-fibroblast cell sheets for accelerated wound healing in a clinically relevant type 2 diabetic rat model. Cytotherapy 2024; 26: 360-71. https://doi.org/10.1016/j.jcyt.2024.01.003.

[163] Jiang D, Qi Y, Walker NG, Sindrilaru A, Hainzl A, Wlaschek M, et al. The effect of adipose tissue derived MSCs delivered by a chemically defined carrier on full-thickness cutaneous wound healing. Biomaterials 2013; 34: 2501-15. https://doi.org/10.1016/j.biomaterials.2012.12.014.

[164] Shi M, Gao Y, Lee L, Song T, Zhou J, Yan L, et al. Adaptive gelatin microspheres enhanced stem cell delivery and integration with diabetic wounds to activate skin tissue regeneration. Front Bioeng Biotechnol 2022; 10: 813805. https://doi.org/10.3389/fbioe.2022.813805.

[165] Sheng W, Song Q, Su X, Lu Y, Bai YZ, Ji FK, et al. Sodium alginate/gelatin hydrogels loaded with adipose-derived mesenchymal stem cells promote wound healing in diabetic rats. J Cosmet Dermatol 2023; 22: 1670-9. https://doi.org/10.1111/jocd.15631.

[166] Calligaris M, Zito G, Busà R, Bulati M, Iannolo G, Gallo A, et al. Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use. Front Cell Dev Biol 2024; 12: 1385712. https://doi.org/10.3389/fcell.2024.1385712.

[167] Yu SP, Wei Z, Wei L. Preconditioning strategy in stem cell transplantation therapy. Transl Stroke Res 2013; 4: 76-88. https://doi.org/10.1007/s12975-012-0251-0.

[168] Luo Z, Fu X, Jiang H, Meng W, Jin S, Cai Y, et al. Multifunctional and immunoregulatory microenvironment-responsive hydrogel for whole course management of infected diabetic wounds. Chem Eng J 2024; 497: 154924. https://doi.org/10.1016/j.cej.2024.154924.

[169] Abtahi S, Chen X, Shahabi S, Nasiri N. Resorbable membranes for guided bone regeneration: critical features, potentials, and limitations. ACS Mater Au 2023; 3: 394-417. https://doi.org/10.1021/acsmaterialsau.3c00013.

[170] Dzobo K, Wilgus TA, Mora VZ, Zoncsich A, de Mezer ville R, Khumalo N, et al. Biomimetic optimization of silicone breast implant integration: insights into wound healing and the foreign body response. Front Bioeng Biotechnol 2025; 13: 1668930. https://doi.org/10.3389/fbioe.2025.1668930.

[171] Zhao Y, Zhao Y, Xu B, Liu H, Chang Q. Microenvironmental dynamics of diabetic wounds and insights for hydrogel-based therapeutics. J Tissue Eng 2024; 15: 20417314241253290. https://doi.org/10.1177/20417314241253290.

[172] Ma XK, Peng Q, Miao GH, Zhang XZ. Functionalized peptide hydrogels: enabling dynamic stage-adaptive modulation for wound healing. Front Cell Dev Biol 2025; 13: 1710175. https://doi.org/10.3389/fcell.2025.1710175.

[173] Nakahata M, Mori S, Takashima Y, Hashidzume A, Yamaguchi H, Harada A. pH-and sugar-responsive gel assemblies based on boronate-catechol interactions. ACS Macro Lett 2014; 3: 337-40. https://doi.org/10.1021/mz500035w.

[174] Zhou Q, Li X, Gao N, Ling G, Zhang P. A multimodal therapy for infected diabetic wounds based on glucose-responsive nanocomposite-integrated microneedles. J Mater Chem B 2024; 12: 1007-21. https://doi.org/10.1039/D3TB02609D.

[175] Ghanbari M, Salkovskiy Y, Carlson MA. The rat as an animal model in chronic wound research: an update. Life Sci 2024; 351: 122783. https://doi.org/10.1016/j.lfs.2024.122783.

[176] Burmeister DM, Supp DM, Clark RA, Tredget EE, Powell HM, Enkhbaatar P, et al. Advantages and disadvantages of using small and large animals in burn research: proceedings of the 2021 Research Special Interest Group. J Burn Care Res 2022; 43: 1032-41. https://doi.org/10.1093/jbcr/irac091.

[177] Parnell LKS, Volk SW. The evolution of animal models in wound healing research: 1993-2017. Adv Wound Care (New Rochelle) 2019; 8: 692-702. https://doi.org/10.1089/wound.2019.1098.

[178] Tan MML, Chin JS, Madden L, Becker DL. Challenges faced in developing an ideal chronic wound model. Expert Opin Drug Discov 2023; 18: 99-114. https://doi.org/10.1080/17460441.2023.2158809.

[179] Sullivan TP, Eaglstein WH, Davis SC, Mertz P. The pig as a model for human wound healing. Wound Repair Regen 2001; 9: 66-76. https://doi.org/10.1046/j.1524-475x.2001.00066.x.

[180] Hofmann E, Fink J, Pignet AL, Schwarz A, Schellnegger M, Nischwitz SP, et al. Human in vitro skin models for wound healing and wound healing disorders. Biomedicines 2023; 11: 1056. https://doi.org/10.3390/biomedicines11041056.

[181] von Kobbe C. Targeting senescent cells: approaches, opportunities, challenges. Aging 2019; 11: 12844-61. https://doi.org/10.18632/aging.102557.

[182] Zhang B, Yang Y, Yi J, Zhao Z, Ye R. Hyperglycemia modulates M1/M2 macrophage polarization via reactive oxygen species overproduction in ligature-induced periodontitis. J Periodontal Res 2021; 56: 991-1005. https://doi.org/10.1111/jre.12912.

[183] Castleberry SA, Almquist BD, Li W, Reis T, Chow J, Mayner S, et al. Self-assembled wound dressings silence MMP-9 and improve diabetic wound healing In vivo. Adv Mater 2016; 28: 1809-17. https://doi.org/10.1002/adma.201503565.

[184] Du L, Lin C, Hu H, Zhao Y, Liao J, Al-Smadi F, et al. Recent advances and challenges in hydrogel-based delivery of immunomodulatory strategies for diabetic wound healing. Theranostics 2026; 16: 516-44. https://doi.org/10.7150/thno.117949.